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Monitoringofintracranialpressure(ICP)hasbeenusedfordecadesintheﬁeldsofneurosurgeryandneurology.Therearemultiple
techniques: invasive as well as noninvasive. This paper aims to provide an overview of the advantages and disadvantages of
the most common and well-known methods as well as assess whether noninvasive techniques (transcranial Doppler, tympanic
membrane displacement, optic nerve sheath diameter, CT scan/MRI and fundoscopy) can be used as reliable alternatives to
the invasive techniques (ventriculostomy and microtransducers). Ventriculostomy is considered the gold standard in terms
of accurate measurement of pressure, although microtransducers generally are just as accurate. Both invasive techniques are
associatedwithaminorriskofcomplicationssuchashemorrhageandinfection.Furthermore,zerodriftisaproblemwithselected
microtransducers. The non-invasive techniques are without the invasive methods’ risk of complication, but fail to measure ICP
accurately enough to be used as routine alternatives to invasive measurement. We conclude that invasive measurement is currently
the only option for accurate measurement of ICP.
1.Introduction
The Scottish anatomist Alexander Monro ﬁrst described the
intracranial pressure in 1783 [1, 2]. Monro proposed that
(1) the brain is encased in a rigid structure; (2) the brain is
incompressible; (3) the volume of the blood in the cranial
cavity must therefore be constant; (4) a constant drainage
of venous blood is necessary to make room for the arterial
supply. Monro’s colleague George Kellie of Leith supported
M o n r o ’ so b s e r v a t i o n ss o m ey e a r sl a t e rb a s e do na u t o p s i e so f
humans and animals [3]. These assertions became known
as the Monro-Kellie hypothesis or doctrine. However, both
were missing a crucial component: the cerebrospinal ﬂuid
(CSF). The Flemish anatomist Vesalius had described ﬂuid-
ﬁlled ventricles back to the sixteenth century, though this
view had never been broadly accepted. Not until the French
physiologist Franc ¸ois Magendie in 1842 through animal
experiments punctured the cisterna magna and analyzed the
CSF, was the idea of ﬂuid in the brain accepted [4].
With this new knowledge in mind, the English physician
George Burrows proposed in 1846 the idea of a reciprocal
relationship between the volumes of CSF and blood, that
is, an increase in one causes a decrease in the other and
introduced CSF as a factor in the Monro-Kellie doctrine [5].
In 1926, Harvey Cushing, American neurosurgeon, for-
mulated the doctrine as we know it today [6], namely, that
with an intact skull, the volume of the brain, blood, and
CSF is constant. An increase in one component will cause
a decrease in one or both of the other components.
This relationship provides a compensatory reserve, also
called spatial compensation. It is 60–80mL in young persons
and 100–140mL in elderly, mainly due to cerebral atrophy
[7]. The volume/pressure curve is shown in Figure 1.
The ﬁrst part of the curve is characterized by a very
limited increase in pressure due to the compensatory reserve
being large enough to accommodate the extra volume. With
increasing volume, the compensatory reserve is eventually
exceeded, causing a rapid increase in pressure.
Normal ICP varies with age and body posture but is
generally considered to be 5–15mmHg in healthy supine
adults, 3–7mmHg in children and 1,5–6mmHg in infants
[7–12].2 Critical Care Research and Practice
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Figure 1: The relationship between intracranial pressure and
volume.
In cases of elevated ICP or circulatory hypotension,
the cerebral perfusion pressure (CPP) is decreased. CPP is
calculated by subtracting ICP from the mean artery pressure
(MAP), deﬁned as the sum of the diastolic pressure added
to a third of the diﬀerence between systolic and diastolic
pressure.
Under normal physiological conditions, the cerebral
autoregulation maintains a constant ﬂow of blood to the
brain by dilating or constricting the arterioles. However,
t h i sa u t o r e g u l a t i o ni so n l ye ﬀective with a MAP between
50 and 150mmHg. Pressure above the upper limit of
autoregulation will cause hyperemia and cerebral edema.
Pressures below the limit lead to insuﬃcient blood ﬂow
and cerebral ischemia, thereby promoting edema formation,
which is ultimately associated with a poor patient prognosis.
Any lesion of the brain can cause a state of vasomotoric
paralysis, where autoregulation is “set out of play,” and
cerebral blood ﬂow is entirely dependent on CPP [7, 8, 13–
16].
Additionally,elevatedICPcancauseherniationwithhigh
risk of irreversible brain damage and death [7, 8, 17, 18].
Treatment designed to lower ICP should be initiated at
pressures above 15–20mmHg, depending on the cause of
elevated pressure [8, 17].
According to the American Brain Trauma Foundation
[19], ICP monitoring is indicated in all cases of traumatic
brain injury with a Glasgow Coma Scale score (GCS)
between 3–8 and an abnormal CT scan, that is, one showing
hematomas, contusion, swelling, herniation, or compressed
basal cisterns. Patients with a GCS of 3–8 but a normal CT
scan should be monitored if two or more of the following
conditions are present: age over 40, uni- or bi-lateral motor
posturing, or systolic blood pressure under 90mmHg.
Causes of elevated ICP are numerous, and ICP moni-
toring is used in patients with various neurological, neu-
rosurgical, and even medical conditions such as hepatic
encephalopathy(Table 1).Nouniversallyacceptedguidelines
exist, and indications for ICP monitoring vary considerably
between hospitals [8, 20–22].
ICP monitoring in the pediatric population poses special
challenges as well as additional noninvasive techniques of
Table 1: Conditions where ICP-monitoring is used.
Traumatic head injury
Intracerebral hemorrhage
Subarachnoid hemorrhage
Hydrocephalus
Malignant infarction
Cerebral edema
CNS infections
Hepatic encephalopathy
Modiﬁed from Smith [8].
ICP measurement. This will not be addressed further in this
paper; however, another useful review is available addressing
this topic [23].
Several questions arise when performing ICP monitor-
ing, not only concerning the type of pressure monitor, but
also concerning the optimal location of monitoring and
where local pressure gradients may inﬂuence measurements.
I nt h i sc o n t e x t ,i ti si m p o r t a n tt oa d d r e s ss p e c i ﬁ c
conditions, such as communicating or noncommunicating
hydrocephalus as well as patients with idiopathic intracranial
hypertension, in which there seems to be no transmantle
pressure gradient across the ventricular wall [24, 25].
Additionally, in patients with subarachnoid hemorrhage or
spontaneous ganglionic hemorrhage, the true intracranial
pressure may be estimated by lumbar cerebrospinal ﬂuid
pressure [26, 27].
In general, there seems to be a consensus that smaller
pressure gradients within the central nervous system do
exist across speciﬁc compartments, and that they may be
exacerbated due to trauma both with and without acute
expanding lesions [28–31]. At present, there does not seem
to be evidence to support claims of signiﬁcant pressure
gradients under physiological conditions [25, 32].
Early descriptions of pressure gradients [33–36]
described diﬀerences in pressure between diﬀerent compart-
ments in the cranial vault as well as along the craniospinal
axis. Later reports—as well as experiments in a porcine
model—showed compartmentalized ICP pressure gradients
[28, 37, 38], indicating that ICP may possibly be best
monitored as close as possible to an expanding mass lesion.
To date no studies have conclusively been able to
demonstrate how often—and under what circumstances—
pressure gradients appear as well as whether bilateral ICP
monitoring should be undertaken routinely. However, in
the evaluation of trauma patients, the danger of localized
elevationsofICPshouldbetakenintoaccountwhenICPand
clinical symptoms diﬀer markedly.
Another pitfall in the clinical use of ICP monitoring is
in determining the validity of the obtained pressure value.
Access to a high-resolution view of the intracranial pressure
waveformenablesmoreaccurateanalysisoftheobtainedICP
as highlighted by the following examples. Electrostatic dis-
charges may cause both rapid shifts of ICP as well as gradual
drifts, which may escape the attention of the clinician [39].
Attention to the mean wave amplitude will show increasing
amplitude at increasing ICP, while ICP shifts due to elec-
trostatic discharges will not be accompanied by increasingCritical Care Research and Practice 3
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Figure 2: Propagation of the cardiac pulse pressure signal.
mean wave amplitude. Furthermore, in performing basic
checks of whether the ICP signal is truly representative of the
intracranial pressure, the clinician should ensure that there
is in fact an oscillating pressure curve with the progressively
decreasing P1, P2, and P3 notches present, indicating
propagation of the cardiac pulse pressure signal (Figure 2).
Further information is found in the pulse pressure signal,
with reversal of the P1 and P2 notches reﬂecting a state of
disturbed autoregulation. A complete absence of a pressure
curve may additionally be seen following craniectomy and in
postoperative pneumencephalon.
More advanced pressure curve analysis may also be
employed by identifying Lundberg A- and B-waves [40]. A-
waves (also known as plateau waves) are characterized by
rapid increase and decrease of pressure to 50–100mmHg
lasting from 5 to 20 minutes. Their duration varies and will
oftenappearirregularlywithoutforewarning.Theyareasign
of more severe loss of cerebral autoregulation. The rhythmic
oscillating B-waves appear with a frequency of 1/2–2 per
minute, and may be a sign of cerebral dysfunction, but may
in certain cases also be physiological phenomena [41].
2.InvasiveMethods ofMeasuringICP
Several diﬀerent invasive methods of measuring ICP exist.
Depending on the technique, ICP measuring can be under-
taken in diﬀerent intracranial anatomical locations: intra-
ventricular, intraparenchymal, epidural, subdural, and sub-
arachnoidal. Additionally, in patients with communicating
CSF pathways, ICP may under certain circumstances be
assessed by lumbar puncture [26, 27, 42, 43], as mentioned
in the above chapter.
2.1. External Ventricular Drainage (EVD). Invasive monitor-
ing using the EVD technique, where a catheter is placed into
one of the ventricles through a burr hole, is considered the
gold standard [8, 44–48] of ICP monitoring. In addition to
measuring ICP, this technique can also be used for drainage
of CSF and administering of medicine intrathecally, for
example, antibiotic administration in cases of ventriculitis,
possibly resulting from EVD placement itself. During long-
term CSF drainage through an EVD, compression of the ven-
tricularsystemduetoprogressiveedemaformationmayarise
and block proper EVD drainage. Additionally, EVD place-
ment may be indicated to drain posttraumatic hemorrhage.
A word of caution applies for those cases, where a
deﬁnable, abnormal mass is responsible for intracranial
hypertension, and an EVD is inserted for pressure relief. In
these cases, caution is advised, since the acute CSF drainage
can displace the intracerebral structures, and in severe cases
even provoke subinkarceration [49].
Surgical placement of EVD is seen as a minor surgi-
cal procedure with few risks, but has nevertheless been
associated with hemorrhagic and infectious complications.
Regarding the technique and placement for the EVD,
traditionally, a coronal burr-hole approach at the Kocher’s
point, with the tip of the EVD located in the 3rd ventricle is
seen as the method of choice, with alternative methods such
as the Frazier burr-hole (occipital-parietal), Keen’s point
(posterior-parietal) and Dandy’s point (occipital) as sec-
ondary options. Nevertheless, the issue is still under debate,
and there has been no general consensus in this ﬁeld [50].
Depending on ventricular size, EVD placement may be
diﬃcult, especially in younger patients with a very slender
ventricular system (Figure 3(a)). In the elderly, we often see
a widened ventricular system due to age-dependent atrophy,
as mentioned earlier (Figure 3(b)).
Focusing on “postoperative hemorrhage,” a review [51]
including articles from 1970 and onwards, found hemor-
rhagic complications in 5,7% of cases on average. This num-
ber covers signiﬁcant diﬀerences in incidence, depending on
whether a routine CT scan was performed after the proce-
dure. Not surprisingly, hemorrhages were discovered more
ofteninpatientswhounderwentaCTscan(10,06%),thanin
those who were not routinely scanned after surgery (1.53%).
The majority of hemorrhages discovered were of no clinical
importance. Of the total amount of hemorrhages, 0,61%
were of clinical importance, that is, causing neurological
deﬁcits, required surgical intervention, or were fatal.
Another study [52] with a total of 188 patients with
EVDs, in which the patients were CT scanned after EVD
placement, showed “postoperative hemorrhages” in 41%
of cases, though only 10,6% had hemorrhages larger than
15mL or with an intraventricular component. One patient
(0,53%) developed a subdural hematoma requiring surgical
drainage.
Another complication in EVD treatment is bacterial
colonization of the catheter with subsequent retrograde
infection. This encompasses a wide array of conditions, from
benign skin infections to ventriculitis, meningitis, and fatal
septicaemia.4 Critical Care Research and Practice
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Figure 3: Diﬀerences in ventricular size in (a) young and (b) elderly patients.
Review articles on this subject [53, 54] have shown a
frequency of catheter-related infections in the range of 0–
27%; however, the deﬁnition of a catheter-related infection
varies tremendously [54]. The majority of reviewed articles
used a positive CSF culture obtained from the EVD or drawn
via a lumbar puncture [54]. However, it is important to note
that a positive CSF culture can stem from other sources, such
as cutaneous contamination during the removal process.
Factors shown to predispose towards a higher infection
rate included; prolonged EVD treatment time of more
than ﬁve days, frequent CSF sampling rate, intraventricular
or subarachnoid hemorrhage, cranial fracture with CSF
leakage and nonsterile EVD insertion [54–56]. The primary
factor disposing towards a lower infection rate was the
subcutaneous tunneling [53].
Minimizing the above predisposing factors, Dasic et al.
[57] managed to achieve a signiﬁcant decrease in the rate of
infection, from 27 to 12%, in 95 patients with a total of 113
EVD insertions, by performing the procedure in the sterile
environment of a operating theatre, with the use of pro-
phylactic antibiotics, tunneling the catheter subcutaneously
at least 10 centimeters from the burr-hole, avoiding routine
sampling of CSF (unless clinically indicated) and by not
changing the catheter (unless clinically indicated).
Strict adherence to sterile practice is also—according
to Tse et al.—the reason for the low rate of infection in
another large retrospective study with 328 patients and 368
EVDs [58]. Over 4 years a mean infection rate of 2,98%
was reported. They also found, that neither the duration of
EVD treatment, surgical revision, urokinase installation, nor
preoperative intracranial hemorrhage increased the risk of
infection.
Concerning the use of prophylactic antibiotics prior to
surgery, Beer et al. [53] argue against this because of the
risk of infection with more virulent organisms as well as
a theoretically increased resistance to antibiotics. Antibiotic
impregnated catheters are an alternative and have proved
very eﬀective in reducing the rate of infection [59, 60];
however, they present the same risks concerning resistance
[53, 57]. Another option is using catheters impregnated with
silver nanoparticles. This technique has good antimicrobial
properties in vitro [61], but has not been tested thoroughly
in vivo. A pilot study conducted by Lackner et al. [62]
with19patientstreatedwithsilvernanoparticleimpregnated
catheters, and 20 controls with regular intraventricular
catheters, showed a signiﬁcant lower incidence of catheter-
associates ventriculitis in the test population (zero) than the
controls (ﬁve). Similar optimistic results were reported from
Fichtner et al. [63], that retrospectively reviewed a total of
164 consecutive patients, 90 with a standard EVD and 74
with a silver-bearing EVD, and found a signiﬁcant reduction
in the occurrence of: a positive CSF culture, colonization of
the catheter tip, and liquor pleocytosis in the silver-bearing
EVD group compared to the group with standard EVD
(18,9% versus 33,7%; P = 0,04). However, both studies
are relatively small, and therefore a larger study with higher
statistical power or more centers reproducing the results is
needed in order to draw any ﬁrm conclusions.
Another factor contributing to increased infection rate
is incorrect placement of the catheter or a defect catheter.
Saladino et al. [64] found by retrospectively reviewing a
patient population of 138, that 12,3% of all catheters were
malplaced either intraparenchymal or extraventricular. This
in turn resulted in reoperation in several cases; a factor
contributing to higher infection rate. These malplacements
canalsoresultininjuriestoimportantcerebralstructures,for
example, basal ganglia, thalamus, the internal capsule, and
even penetration of the ﬂoor of the 3rd ventricle.Critical Care Research and Practice 5
A so-called “Ghajar guide” has been shown to increase
the amount of correctly positioned catheters as compared
to insertion by hand [65]; however, according to a survey
amongst American neurosurgeons, only 3% use the guide
on a regular basis [66] .T h er a t eo fd e f e c t i v ev e n t r i c u l a r
catheters has been found to be 6,3%, the cause often being
intraparenchymal placement, blockage with pieces of brain
matter and blood clots [67–69].
2.2. Microtransducer ICP Monitoring Devices. This group of
invasive ICP monitoring devices can be divided into ﬁber
optic devices, strain gauge devices, and pneumatic sensors.
Fiber optic devices, such as the Camino ICP Monitor,
transmit light via a ﬁber optic cable towards a displaceable
mirror. Changes in ICP will move the mirror, and the
diﬀerences in intensity of the reﬂected light are translated
to an ICP value. The Codman MicroSensor, the Raumedic
Neurovent-P ICP sensor, and the Pressio sensor belong
to the group of piezoelectric strain gauge devices. When
the transducer is bent because of the ICP, its resistance
changes, and an ICP can be calculated. Pneumatic sensors
(Spiegelberg) use a small balloon in the distal end of the
catheter to register changes in pressure, and additionally
allows quantitative measurement of intracranial compliance.
Depending on the technique, monitoring can be done in the
intraventricular, intraparenchymal, epidural, subdural, or
subarachnoidal compartment.
The ICP microtransducers most widely used, are those
measuring ICP intraparenchymally, usually placed in the
right frontal region at a depth of approximately 2cm. How-
ever, depending on known or suspected pressure gradients
across intracranial compartments, the placement can be
modiﬁed.
Regarding epidural ICP monitoring, currently it does
not provide the necessary accuracy for routine use. One
report shows that the epidural Camino sensor considerably
overestimated ICP with a mean of about 9mmHg but
extending to almost 30mmHg [70]. Another study showed
am a r k e d l yd i ﬀering mean ICP, but comparable parameters
of pulsatile ICP (mean wave amplitude and wave rise time)
[71].
A comparison between epidurally and subdurally placed
pressure sensors [72] showed lower ICP values measured
in the subdural space, but obtaining almost equal ICP
values in intervals above 20mmHg. In a newer study
comparing lumbar cerebrospinal ﬂuid pressure to epidural
and subdural ICP [73], an excellent correlation was found
between the lumbar and subdural pressure measurements.
However, higher pressure values were consistently found
for ICP measured in the epidural space with increasing
distance between the lumbar and epidural values at higher
pressure intervals. The authors concluded that the higher
ICP in the epidural space was due to physiologically diﬀerent
pressures in the two compartments and not due to technical
aspects.
For current use in critical care, subdural sensors may
be considered for use if there is no suspicion of focal ICP
elevations with potential for causing intercompartmental
pressure gradients. However, this will seldom be the case,
and intraparenchymal or intraventricular monitors should
be considered the standard choice. Complications are, as
with EVDs, mainly the risk of hemorrhage and infection.
A large study including 1000 patients with a total of 1071
CaminoICPMonitors[74],foundretrospectively,thatofthe
574 probe tips examined, 8,5% were positive for bacterial
growth by subsequent cultivation, even though a positive
culture growth could stem from cutaneous contamination
during the removal process. A control CT scan was under-
taken in 92,2% of patient cases and showed an incidence of
hemorrhage in 2,5% of cases. In 6 cases (0,66%), a clinically
signiﬁcant hemorrhage was found (4 intraparenchymal and
2 epidural). Technical errors were present in 4,5% of cases,
most often related to the ﬁber optic cable itself. Similar study
by Piper et al. [75] found 10% faulty sensors in a study
that included a total of 50 Camino monitors. Another study
[76], in which 328 patients with a Camino monitor were
examined, showed hemorrhage in 1,1% of cases, infection,
in 4,75% and technical errors in 3,14%.
The Codman MicroSensor has also been thoroughly
examined in several studies; among 120 patients with a
Codman MicroSensor, Hong et al. [77] found no incidents
of hemorrhage postoperatively (85% of the included patient
were CT scanned after insertion). The authors state that no
infections were diagnosed in the study population; however,
one patient had a fever and a positive bacterial culture
from the catheter tip, but no bacterial growth in the CSF.
A large study by Koskinen and Olivecrona [78] state, that
after insertion of almost 1000 Codman MicroSensors, only 3
incidentsofsurgicallyrelatedhemorrhageswerefound,none
of which required surgical intervention. No infections were
linked to the placement of the MicroSensor.
Regarding the Raumedic Neurovent-P Sensors, Citerio et
al. [79] tested a total of 99 sensors in an equal number of
patients. No CNS infections were registered. 2 patients had
smaller hemorrhages, not requiring intervention.
The relatively new Pressio sensor has yet to be tested
thoroughly in vivo. Only clinical study currently available, is
thatb yL esc otetal.[80],lookingattheaccuracyof15Pressio
sensors and 15 Codman MicroSensors in comparison to ICP
measurements undertaken by an EVD. The two types of
sensors performed much alike, albeit with a mean diﬀerence
of ±7mmHg compared to ICP values acquired by the EVDs.
Complications were not recorded.
TheSpiegelbergsensorhasbeentestedbyLangetal.[81],
without any incidence of hemorrhage among all 87 patients
(all patients were CT-scanned after insertion). None of the
patientsshowedclinicalsignsofmeningitis.Inthreepatients,
a leak related to the sensor resulted in incorrect measure-
ments. Kiening et al. [82] additionally tested the Spiegelberg
sensor for use in continuous intracranial compliance (cICC)
monitoring in ten patients with TBI and found poor overall
cICC data quality as well as poor predictive capabilities
in identifying increased ICP and correlation with cerebral
hypoxia. Despite unsatisfactory results in the current clinical
care setting, the same authors [83] later found a correlation
between increasing age and decreasing compliance and
speculated that this correlation might contribute to the
poorer outcome seen in elderly patients after TBI.6 Critical Care Research and Practice
Table 2: Comparison of microtransducer ICP monitoring devices.
Technology Rate of
infection Rate of hemorrhaging Technical errors Zero drift
Camino ICP
Monitor Fiber optic 8,5% [74] 2,50% (0,66% clinical
signiﬁcant) [74] 4,5% [74] Mean 7,3 ± 5,1mmHg (range −17 to 21mmHg)
[74]
4,75% [76]1 , 1 % [ 76] 10% [75] Mean −0,67mmHg (range −13 to 22mmHg) [75]
3,14% [76] Mean 3,5 ± 3,1mmHg (range 0 to 12mmHg) [84]
Codman
MicroSensor Strain gauge 0% [77]0 % [ 76] n/a Mean 0,9 ± 0,2mmHg (range −5 to 4mmHg) [78]
0% [78]
∼0,3% (0% clinical
signiﬁcant) [78]
Mean 0,1 ± 1,6mmHg/100 hours of monitoring
[80]
Mean 2,0mmHg (range −6 to 15mmHg) [87]
Raumedic
Neurovent-P ICP
sensor
Strain gauge 0% [79] 2,02% (0% clinical
signiﬁcant) [79] n/a Mean 0,8 ± 2,2mmHg (range −4 to +8mmHg)
[79]
1,7 ± 1,36mmHg (range −2 to 3mmHg) [84]
In vitro: 0,6 ± 0,96mmHg (range 0 to 2mmHg)
[88]
Pressio Strain gauge n/a n/a n/a Mean −0,7 ± 1,6mmHg/100 hours of monitoring
[80]
In vitro: 7-day drift <0,05mmHg [89]
Spiegelberg Pneumatic 0% [81]0 % [ 81] 3,45% [81] Mean < ± 2mmHg [81]
It is worth mentioning, that the Neurovent-P sensor,
the Spiegelberg sensor and the Codman MicroSensor are
compatiblewithmagneticresonanceimaging(MRI)without
any danger to the patient. The Camino monitor and Pressio
sensor contain ferromagnetic components, and therefore
patients with these devices cannot undergo MRI [84–86].
Generally, several of the above studies concluded that
when it comes to measuring ICP, microtransducers are just
as accurate as the EVDs [69, 81]. However, microtransducers
share a common disadvantage, in that no recalibration is
possible after placement; though the Spiegelberg catheter is
anexceptionfromthisrule,asitrecalibratesitselfeveryhour.
TheEVDs,onotherhand,havetheadvantageofthattheycan
berecalibratedatanytime,simplybyresettingthetransducer
to atmospheric pressure at the level of the so called zero
reference point (Foramen of Monro/Tragus). The amount of
CSFdraineddependsonthepressuregradientinsidetheCSF
cavity and the resistance of the CSF drainage, the resistance
being deﬁned by the pressure gradient of the CSF has to
overcome to reach the level of the drip chamber. This means
that the position of the drip chamber relative to the CSF
space is the crucial factor for the amount of drained CSF.
When recording ICP, it is also of utmost importance that
the “three-way” valve system is closed to drainage, so that
the true ICP is measured, otherwise it will be the drainage
pressure that is recorded.
Problems often arise due to incorrect setup of the system,
mainly resulting in a false pressure gradient and secondarily
problems in insuﬃcient CSF drainage, as well as false ICP
measurements du to incorrect use of the “three-way” valve.
The lack of continuous calibration can cause the sensor
to report imprecise ICP values. The diﬀerence between the
starting ICP value when the sensor is calibrated (0mmHg),
and the ICP value that is measured when the sensor is
removed is termed “zero drift.” A large diﬀerence between
these two ICP measurements indicates, that the ICP mea-
sured while the device was implanted in the patient, was
not the “true” ICP at any given moment. Therefore, the
cumulative pressure diﬀerence can have important impli-
cations for the treatment and prognosis of the patient.
Data regarding diﬀerences between microtransducer ICP
monitoring devices is summarized in Table 2.
3. NoninvasiveMethods of Measuring
The idea of a noninvasive method of measuring ICP is
captivating, as complications seen in relation to the invasive
methods of ICP measuring, that is, hemorrhage and infec-
tion,areavoidable.Diﬀerenttechniqueshavebeenproposed;
however, in this paper we will focus on the ones most widely
familiar.
3.1. Transcranial Doppler Ultrasonography (TCD). The TCD
technique applies ultrasound to initially measure the blood
ﬂow velocity in the middle cerebral artery. The diﬀerence
between systolic and diastolic ﬂow velocity, divided by the
mean ﬂow velocity, is called the pulsatility index (PI):
PI =
systolic ﬂow velocity −diastolic ﬂow velocity
mean ﬂow velocity
. (1)
PI is found to correlate with invasively measured ICP [90–
92], and correlation coeﬃcients between 0,439 and 0,938
have been found. Bellner et al. [90] reported the best
correlation and a mean deviation of ±4,2mmHg from
invasivelymeasuredICP.AdeviationofthissmallmagnitudeCritical Care Research and Practice 7
is clinically acceptable. However, this small magnitude of
deviation only applies to ICP values lower than approx.
30mmHg. At higher ICP values, the magnitude of deviation
increases, making accurate ICP measurements impossible.
The apparently high correlation includes great individual
variations in the data. It is seen that a PI of 1 can mean
anything from a few mmHg to about 40mmHg. A variation
of this magnitude is clearly unacceptable for clinical use.
Behrens et al. [93] described a similar large spread in
their experiment, where 10 patients with idiopathic normal
pressure hydrocephalus had their ICP artiﬁcially heightened
or lowered by lumbar infusion. ICP calculated from PI was
compared to ICP measured by a Codman MicroSensor.
They reported that an ICP of 20mmHg found by using
PI had 95% conﬁdence intervals of −3,8 to 43,8mmHg.
Brandi et al. [94] also came to the conclusion that PI-
calculated ICP is too uncertain. In their study, 45 sedated
patients with severe traumatic brain injury, each monitored
with a Raumedic probe, were examined daily using TCD.
Their PI and calculated ICP were compared to the invasively
found ICP. The best correlation was found by using the
calculations proposed by Bellner et al. [90], which yielded a
mean diﬀerence of −3,2 ± 12,6mmHg.
Apart from being imprecise, the technique requires
training and repetitive exercise [95], and there is also
intra- and inter-observer variations as noted earlier [95–98].
Furthermore, the technique cannot be used on 10–15% of
thepatientsduetotheultrasoundnotbeingabletopenetrate
the skull (the so-called bone window) [99].
3.2. Tympanic Membrane Displacement (TMD). The tech-
nique takes advantage of the communication of the CSF
and the perilymph via the perilymphatic duct. Stimulation
of the stapedial reﬂex causes a movement of the tympanic
membrane, which is shown to correlate to ICP [100, 101].
Stapes rests on the oval window, which is covered by a
membrane. This membrane is ﬂexible, meaning that the
pressureoftheﬂuidinthecochleaaﬀectshowthemembrane
and stapes are positioned and how they move. A quantitative
measurement of this movement is the fundament of this
technique. However, the technique is not without ﬂaws;
Shimbles et al. [102] tested the technique on 148 patients
with intracranial pathology (hydrocephalus and benign
intracranial hypertension) and on 77 healthy controls. The
technique was applied successfully on 70% of the healthy
subjects, but only on 40% in the patient population. It was
noted, that the low rate of success was mainly due to the
perilymphatic duct being less passable with age, especially
after the age of 40.
Furthermore, a subgroup of cases in the patient popula-
tion were invasively ICP monitored at the time of the exper-
iment. A correlation between the invasively and the TMD
measuredICPvalueswerefound.However,intersubjectvari-
ability was so great that the predictive limits of the regression
analysis was an order of magnitude greater than normal ICP
range, thus precluding the method for clinical use [102].
3.3.OpticNerveSheathDiameter(ONSD). Theopticnerveis
part of the central nervous system, and therefore surrounded
by the dural sheath. Between the sheath and the white matter
is a small 0,1-0,2mm subarachnoid space, which communi-
cates with the subarachnoid space surrounding the brain. In
cases of increased ICP, the sheath expands. Changes in the
diameter of the nerve sheath can be visualized using transoc-
ular ultrasound. Several studies [103–106]h a v ei n v e s t i g a t e d
the correlation between the nerve sheath diameter and
invasively measured ICP. A correlation coeﬃcient of between
0,59–0,73 has been found. The technique is cheap and
eﬃcient; the examination takes around 5 minutes per patient
[104]. However, as with all ultrasonography, it requires
training and has intra- and inter-observer variance, though
these variations are minor. Mean intraobserver variance ±
0,1-0,2mm and mean interobserver variance ± 0,2-0,3mm
was found in recent studies [105, 107, 108]. Furthermore, it
is important to mention that several conditions can aﬀect
optic nerve diameter, for example, tumors, inﬂammation,
Graves disease, and sarcoidosis [105, 109]. Patients with
glaucoma and cataract have been excluded from the above
study population, and it is therefore uncertain, whether the
technique can be applied on patients with these common
conditions. Lesions of the orbita or the optic nerve are
present in 10% of all head trauma cases, which can render
measurements with the ONSD impossible.
At present, the technique does not seem to be accurate
enough to be used as a replacement for invasive ICP
measuring methods. It can, however, distinguish between
normal and increased (>20mmHg) ICP. A review article
[109] showed that all included studies found a cutoﬀ value
of 5,00–5,90mm for predicting increased ICP. Sensitivity
was 74–95% and speciﬁcity 79–100%. Another study by
Rajajee et al. [106] recently published even better results,
with sensitivity of 96% and a speciﬁcity of 94% for increased
ICP (>20mmHg) for a ONSD cutoﬀ value of 4,8mm. This
means that this technique can potentially be used as a
screening method for detecting raised ICP in settings, where
invasive ICP monitoring capabilities are not available, that is,
hospitals without access to a neurosurgeon.
3.4. Magnetic Resonance Imaging (MRI) & Computer Tomog-
raphy (CT). In 2000, Alperin et al. investigated the possi-
bilities of using MRI as a noninvasive method of ICP mea-
surement [110]. By using motion-sensitive MRI, pulsatile
arterial, venous, and CSF ﬂow in and out of the cranial
vault during the cardiac cycle was measured. A small volume
change (about 1mL) during the cardiac cycle was found
and calculated from the net transcranial CSF and blood
volumetric ﬂow rates, and the following change in pressure
was estimated from CSF velocity. An elastance index was
derived from the ratio of pressure to volume change and
found to correlate well with invasively measured ICP (R2 =
0,965; P<0,005). However, as Marshall and colleagues
pointed out,careisrequiredin theselectionofrepresentative
image slides as well as choosing the representative blood
vessels [111]. Furthermore, the technique is very sensitive to
diﬀerences in heart rate measured in the circulation contra
the CSF ﬂow rate as well as CSF measurements. Even when
the above was addressed, some subjects displayed signiﬁcant
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thedatagatheredfromindividualcasestobeinterpretedwith
caution [111]. However, if we can accept these shortcomings,
the technique could have a role as a screening tool for identi-
ﬁcation of patients in need of invasive ICP monitoring after
moderate head trauma. It could also play a role in diagnosis
and evaluation of several chronic disorders potentially asso-
ciatedwithincreasedICPvalues,i.e.,hydrocephalus,pseudo-
tumor cerebri, intracranial mass lesions, and so forth [112].
A way of interpreting ICP values from cranial CT scans
has also been investigated; the majority of studies were
conducted in the late 1980s and early 1990s and failed
to show consistent correlation between ICP and CT scan
characteristics [113]. In 2003, Eide reported no signiﬁcant
correlation between actual size (or change in size) of cerebral
ventricles by cranial CT scans and invasively monitored ICP
in 184 consecutive patients [114]. A linear, but ultimately
nonpredictive relationship between baseline ICP and initial
head CT scan characteristics was found by Miller and
colleagues [113]. Similar results were observed by Hiler et
al. who concluded, after looking at 126 patients with severe
traumatic brain injury, that mean ICP values in the ﬁrst 24
hours cannot be predicted by using the Marshall CT scan
classiﬁcation[115].Overall,no method of estimating ICPon
the basis of cranial CT scans currently exists.
3.5. Fundoscopy and Papilledema. Papilledema, or optic disc
swelling, due to raised ICP can be visualized by fundoscopy
andgradedbytheFris´ enScaleinto5categoriesdependingon
signs of disturbed axoplasmic transport. A study employing
fundus photographs showed good reproducibility of this
grading scale among diﬀerent observers, speciﬁcity ranging
between 88–96% and sensitivity between 93–100% [116].
Nevertheless, even though fundoscopy is often used as a
screening method in cases of suspected increase in ICP,
the grading scale is not widely applicable or accepted. The
technique itself is limited to the abilities of the examiner, as
well as the circumstances surrounding the examination, the
examiner requiring good visualization of the optic disc to be
able to detect papilledema [117].
Furthermore, since the process of optic disc swelling
in cases of raised ICP takes time, the technique cannot be
applied in emergency situations with sudden increases in
ICP, such as, trauma [118].
4. Discussion
ICP monitoring techniques are multiple and diverse. Nev-
ertheless, before choosing the technique to apply in critical
care, several factors need to be considered; the precision of
measurements made, the cost of the device as well as the
possible complications and mechanical problems associated
with the individual techniques.
In regards to precision of measuring accurate ICP values,
EVDs are considered the gold standard, closely followed
by microtransducers, which measure ICP almost just as
accurately [69, 81]. The noninvasive techniques have their
greatest shortcomings in this ﬁeld. At present, none of
the above-mentioned noninvasive techniques are accurate
enough to be used in a critical (intensive) care setting.
On the other hand, the noninvasive techniques have their
advantages in completely avoiding complications such as
hemorrhages and infections, which are often associated with
the invasive techniques.
Clinically relevant hemorrhaging, that is, those causing
neurological deﬁcits or requiring surgical intervention occur
in about 0,5% of cases with EVDs [51, 52], and approx-
imately the same percentage applies for microtransducer
techniques [74, 76–78, 81]. A clinically relevant hemorrhage
percentage of 0,5% associated to the invasive techniques may
not seem as much, but one has to keep in mind that this
means one in 200 patients will have a worsened clinical
outcome solely due to the application of an invasive ICP
monitoring technique. This is an intensely debated issue,
especially given the fact that general guidelines for ICP
monitoring are not widely accepted, resulting in variations
for application of invasive ICP monitoring among hospitals
[8, 22, 46]. One could fear that a too liberal approach for
invasive ICP monitoring could result in unnecessary wors-
ened clinical patient outcome, without the monitoring itself
having any relevance to the way these patients are treated.
The same words of caution can then applied in relation
to the relatively high postoperative infection frequencies of
up to 27% [53] in relation to the insertion of an EVD. A
signiﬁcant number of these patients will develop systemic or
cerebral infections, with subsequent risk of increased mor-
tality and morbidity, for example, hydrocephalus, infarcts,
epilepsy, or cranial nerve palsy [119]. As Dasic et al. [57]
showed, the only way to minimize the risk for postoperative
infectionistostrictlyfollowsterileguidelines.Itisalsoworth
mentioning that patients with microtransducers generally
have a lower rate of postoperative infections than patients
with EVDs, ranging between 0–8,5% [74, 76–78, 81].
The rate of nonfunctioning EVDs has been found to
be 6,3% [69]. One would like to think that this relative
simple technology would be more reliable than the more
complex microtransducers. However, microtransducers are
only defective in 3,14–5,0% of cases [74–76, 81]. In most
part, the relatively high percentage of malfunctioning EVDs
isduetotheEVDbeingplacedintraparenchymalyorblocked
with pieces of brain matter and blood clots [67–69].
For the reviewed noninvasive techniques, there are
several patient categories for which the measuring technique
cannot be applied in critical care practice. In 10–15% of
patients investigated using TCD, no valid measurements
c o u l db em a d e[ 99]. In measurements using TMD, the ﬁgure
was 60% [102], and for ONSD 10% [103, 105].
The cost for placing an EVD amounts to around $200
in materials [45, 69]. Microtransducers are more expensive,
given that they require a monitor, with the total cost
easily around several thousand dollars, and the transducers
themselves costing at least $400–600 each [45, 69]. In
addition to the equipment comes also the subsequent cost
of maintaining and replacing it. The noninvasive techniques
require only the single expense of purchasing the device,
afterwhichthedevicescanbeappliedmultipletimeswithout
further costs apart from wages and maintenance.
To summarize, economically and complication wise, the
noninvasive techniques are favored. However, consideringCritical Care Research and Practice 9
Table 3: The diﬀerent technologies compared.
Technology Accuracy Rate of infection Rate of hemorrhaging Cost per patient Miscellaneous
External ventricular
drainage High Low to moderate Low Relatively low
Can be used for drainage of
CSF and infusion of
antibiotics
Microtransducer ICP
monitoring devices High Low Low High
Some transducers have
problems with high zero
drift
Transcranial Doppler
ultrasonography Low None None Low High percentage of
unsuccessful measurements
Tympanic membrane
displacement Low None None Low High percentage of
unsuccessful measurements
Optic nerve Sheath
diameter Low None None Low
Can potentially be used as a
screening method of
detecting raised ICP
MRI/CT Low None None Low
MRI has potential for being
used for noninvasive
estimation of ICP
Fundoscopy
(papilledema) Low None None Low
Can be used as a screening
method of detecting raised
ICP, but not in cases of
sudden raise in ICP, that is,
trauma
the high number of patients where noninvasive techniques
cannot be applied, and more importantly, the low accuracy
of the ICP measurements undertaken, the noninvasive tech-
niquesareless favorable.Thecurrentnoninvasive techniques
are simply not accurate enough to replace the traditional
invasive techniques. This leaves us with the choice between
EVDs and microtransducers. Precision wise, there is not
ag r e a td i ﬀerence between these two techniques, despite
the fact that most microtransducers cannot be recalibrated.
However, in this context it is important to point out that the
Camino MicroSensor has problems with a large zero drift
[74, 75]. Economically, microtransducers are more expen-
sive, but apparently they carry a lower rate of postoperative
infections. EVDs, on the other hand, have the advantage that
they can be used for drainage of CSF and administering of
drugsintrathecally.DrainageofCSFhasbeenusedinroutine
clinical practice for lowering of ICP. However, this has not
beenshowntobetterthecerebralperfusionofthepatientnor
improve the patients’ ﬁnal clinical outcome [120]. Table 3
summarizes the results.
The American Brain Trauma Foundation still has EVDs
as their favored method of ICP monitoring [69]. Whether
EVD or microtransducers is the optimal ICP measuring
technique is a diﬃcult question to answer unambiguously, as
both have advantages and disadvantages as discussed above.
Both can, therefore, be regarded as good options when ICP
monitoring is needed.
But when is ICP monitoring needed in critical care?
As mentioned in the background paragraph, there are no
general guidelines. A thorough evaluation of the literature is
outside the scope of this paper, but we will comment brieﬂy
on the topic. Stein et al. [121] did an extensive review on
all available articles on outcome of severe traumatic brain
injury from the last forty or so years, resulting in 127 case
series, involving more than 125.000 patients. Overall,higher-
intensity treatment with use of ICP monitoring resulted in a
12%lowermortalityrateanda6%betterchanceoffavorable
outcomecomparedtolessaggressivetreatmentandmonitor-
ing approach, where ICP monitoring was not applied. How-
ever, most of the reviewed studies are of a methodologically
limited quality. A recent Cochrane review [22] also sought to
review the literature, but all articles that were obtained had
t ob ee x c l u d e ds i n c en o n ew e r eo fap r o s p e c t i v er a n d o m i z e d
nature and therefore not deemed as “suﬃcient” evidence.
A large part of the evidence advocating ICP monitoring
originates from the late nineteen seventies and early eighties
[122–124], but these studies are of weaker methodological
design. Current studies reporting better survival and out-
come with ICP monitoring include Patel et al. [125]a n d
Fakhry et al. [126]. However, several other studies have
reached the opposite conclusion, indicating worse outcome
as a consequence of ICP monitoring and CPP-oriented
therapy [46, 127–129].
Nevertheless, to this date, no prospective randomized
study of the possible beneﬁts of ICP monitoring has been
done. Current ICP- and CPP-based therapies are based
on diﬀering assumptions of “elevated pressure,” with rec-
ommendation on treatment initiation at ICP levels above
20–25mmHg [17]. It is apparent today that additional
neuromonitoring modalities should supplement ICP in the
critical care setting, thereby increasing patient safety by more
accurately guiding treatment interventions in terms of type,
aggressiveness and duration, including controlled tapering
[130].10 Critical Care Research and Practice
5. Conclusion
This paper sought (1) to provide an overview of “pros” and
“cons” of the most widely used methods of ICP monitoring
and (2) to evaluate whether noninvasive techniques could be
used as an alternative to the invasive techniques in critical
care.
To answer the ﬁrst question, we can conclude that
both EVD and microtransducers are good technologies for
ICP monitoring. Both are accurate in ICP monitoring, but
have risks of complications in the form of postoperative
hemorrhage and infection. Which of these modalities is
preferable, must ultimately be decided by the individual
clinician and department.
To answer the second question, we conclude that
noninvasive techniques lack the accuracy of their invasive
counterparts. Additionally, the noninvasive ICP monitoring
cannot be carried out on a large percentage of patients due
to anatomical variations, leading us to conclude that current
noninvasive techniques cannot be used as an alternative to
the invasive techniques.
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